NCT06058611 Effects of a Computerised Cognitive Stimulation Versus Stimulating Leisure Activities
| NCT ID | NCT06058611 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universidad de Zaragoza |
| Condition | Mild Cognitive Impairment |
| Study Type | INTERVENTIONAL |
| Enrollment | 90 participants |
| Start Date | 2024-04-01 |
| Primary Completion | 2024-05-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 90 participants in total. It began in 2024-04-01 with a primary completion date of 2024-05-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of the study is to evaluate, at the level of global cognition, cognitive neuroconstructs, memory, verbal fluency, ADLs, IADLs, symptoms of depression and anxiety, the effectiveness of a personalised and adapted computerised cognitive stimulation programme (GI1) implemented from Primary Care versus stimulating leisure activities (GI2), in older adults aged 50 years and over with mild cognitive impairment and subjective cognitive impairment living in the community.
Eligibility Criteria
Inclusion Criteria: * ≥ 50 years old, resident in the community. * Diagnosis of MCI or having between 24 and 27 points on the MEC-35 (this score seems to indicate the presence of MCI) (Calero, M. D and Navarro, 2006). * Subjective cognitive impairment (score between 28-31 points on the MEC-35) (Gómez-Soria et al. 2023) Exclusion Criteria: * Institutionalisation. * Taking acetylcholinesterase inhibitors as they may act on global cognition and/or cognitive functions. * Sensory deficits (deafness and blindness) preventing intervention. * Agitation. * Having received cognitive stimulation in the last 12 months.
Frequently Asked Questions
Who can join the NCT06058611 clinical trial?
This trial is open to participants of all sexes, aged 50 Years or older, studying Mild Cognitive Impairment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06058611 currently recruiting?
Yes, NCT06058611 is actively recruiting participants. Visit ClinicalTrials.gov or contact Universidad de Zaragoza to inquire about joining.
Where is the NCT06058611 trial being conducted?
This trial is being conducted at Zaragoza, Spain.
Who is sponsoring the NCT06058611 clinical trial?
NCT06058611 is sponsored by Universidad de Zaragoza. The trial plans to enroll 90 participants.